loader from loading.io

Transthyretin Cardiac Amyloid: 'Dr RR Baliga's "Got Knowledge Doc" Podcasts

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Release Date: 08/27/2022

 Cancer Risk Podcast 3 show art Cancer Risk Podcast 3

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk Podcast 3

info_outline
Cancer Risk Podcast 2 show art Cancer Risk Podcast 2

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk Podcast no 2

info_outline
Cancer Risk show art Cancer Risk

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk

info_outline
Oncometabolites and The Heart show art Oncometabolites and The Heart

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Oncometabolites and The Heart

info_outline
Fasting for Chemotherapy Induced Heart Failure? show art Fasting for Chemotherapy Induced Heart Failure?

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Fasting for Chemotherapy Induced Heart Failure? |Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

info_outline
Food for Thought: Should the FDA, EMA, NCI, NHLBI, ICOS, ACC, AHA, mandate Cardio-Oncologists on Cancer Clinical Trials with Cardiotoxic Drugs?|  Trastuzumab Cardiotoxicity in DESTINY-Breast04 Trial show art Food for Thought: Should the FDA, EMA, NCI, NHLBI, ICOS, ACC, AHA, mandate Cardio-Oncologists on Cancer Clinical Trials with Cardiotoxic Drugs?| Trastuzumab Cardiotoxicity in DESTINY-Breast04 Trial

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203690#.YsoGdaAS_fY.twitter DESTINY-Changing Results for Advanced Breast Cancer | NEJM   Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks? https://www.heartfailure.theclinics.com/article/S1551-7136(11)00037-7/fulltext#.YsoHTLcs3-M.twitter Using a Magnet to Strike Gold https://www.heartfailure.theclinics.com/article/S1551-7136(09)00026-9/fulltext#.YsoG3Cq5rAs.twitter

info_outline
Long-Term Risk of Heart Failure with Trastuzumab show art Long-Term Risk of Heart Failure with Trastuzumab

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Dr RR Baliga's Internal Medicine Podkasts for Physicians: "Got Knowledge Doc?" about Long-Term Risk of HF with Chemotherapy with Trastuzumab

info_outline
Breast Cancer PodCast2 show art Breast Cancer PodCast2

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Breast Cancer PodCast2

info_outline
Connecting the Dots Between Cardio-Oncology & Door-to-GDMT Time for Heart Failure show art Connecting the Dots Between Cardio-Oncology & Door-to-GDMT Time for Heart Failure

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

info_outline
Breast Cancer Risk show art Breast Cancer Risk

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Breast Cancer Risk

info_outline
 
More Episodes

🎧 Transthyretin (TTR) Amyloid: Dr RR Baliga "Got Knowledge Doc" PodKast for Physicians

1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry Scott M. Damrauer, MD; Kumardeep Chaudhary, PhD; Judy H. Cho, MD; et al. JAMA. Dec10th, 2019;322(22):2191-2202. doi:10.1001/jama.2019.17935

2. Treatment of Cardiac Transthyretin Amyloidosis: Emdin M, Aimo A, Rapezzi C, et al. An Update. Eur Heart J 2019;40:3699-3706.

3. Treatment of Cardiac Transthyretin Amyloidosis Dec 13, 2019   |  RR. Baliga, MD, FACC

Transthyretin (TTR) Amyloid: "Hot-off-the-Press Dr RR Baliga MUST KNOW FACTS PodKast"

1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry Scott M. Damrauer, MD; Kumardeep Chaudhary, PhD; Judy H. Cho, MD; et al. JAMA. Dec10th, 2019;322(22):2191-2202. doi:10.1001/jama.2019.17935

2. Treatment of Cardiac Transthyretin Amyloidosis: An Update. Eur Heart J 2019;40:3699-3706.

3. Treatment of Cardiac Transthyretin Amyloidosis Dec 13, 2019   |  RR. Baliga, MD, FACC